Trial intelligence / Profile preview

Nicotinamide as Adjunctive Therapy in Sepsis

NCT07655791Phase 4Completed

Sponsor
Ain Shams University
Start
Mar 2026
Primary completion
Sep 2026
Countries
1
01

Overview

A Phase 4 trial of nicotinamide in sepsis, sponsored by Ain Shams University. Started Mar 2026; status: completed.

02

Drugs

nicotinamide
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT07655791.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07655791.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call